A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2001
11/13/2001	US6316217 Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same
11/13/2001	US6316213 Methods for the early diagnosis of ovarian, breast and lung cancer
11/13/2001	US6316211 ThdF
11/13/2001	US6316210 Genetic suppressor elements against human immunodeficiency virus
11/13/2001	US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001	US6316206 Method for screening comprising cells expressing the CNTF receptor
11/13/2001	US6316204 Methods for detecting fohy030 polypeptide
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316199 Arginase II
11/13/2001	US6316183 Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)
11/13/2001	US6316012 Cosmetic or pharmaceutical composition comprising, in combination, a peroxidase and an anti-singlet oxygen agent
11/13/2001	US6316003 Presenting to the cell an extracellular fusion protein consisting of a cargo moiety and a transport moiety and allowing transport moiety-dependent intracellular delivery of the fusion protein
11/13/2001	US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation
11/13/2001	US6315997 Administering modified antibody which selectively binds human milk fat globule (hmfg) antigen, and competes as well or better with unmodified unmodified antibody for binding the hfmg for reducing tumor growth or reducing size of tumor
11/13/2001	US6315996 Topical lysostaphin therapy for staphylococcus ocular infections
11/13/2001	US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient
11/13/2001	US6315992 Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-β-1
11/13/2001	US6315984 For administration of large-molecule pharmaceuticals, e.g. peptidic drugs, vaccines and hormones
11/13/2001	US6315983 Process for the production of powdered pulmonary surfactant preparations
11/13/2001	US6315978 Bioconjugates and delivery of bioactive agents
11/13/2001	CA2064793C Hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
11/13/2001	CA1341319C Modified hepatocytes and uses therefor
11/13/2001	CA1341318C Dna clones of human placental plasminogen activator inhibitor
11/12/2001	CA2347566A1 Solid compositions exhibiting selective binding to dissolved iron
11/11/2001	CA2345787A1 Biocompatible macromers
11/10/2001	CA2347151A1 Method for screening a substance having promoting activity on hair growth
11/09/2001	CA2305787A1 Cxcr4 antagonist treatment of hematopoietic cells
11/08/2001	WO2001084158A1 Use of the g protein coupled receptor gpr3 to identify appetite control agents
11/08/2001	WO2001084149A2 Diagnostics and therapeutics for macular degeneration-related disorders
11/08/2001	WO2001083781A2 14094, a novel human trypsin family member and uses thereof
11/08/2001	WO2001083780A1 A novel polypeptide, a human methylthioadenosine phosphorylase 37 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083778A1 A novel polypeptide, a human pax protein 10.3 and polynucleotide encoding it
11/08/2001	WO2001083777A1 A novel polypeptide, a human atp dependent serine protein hydrolase 9.1 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083776A1 A novel polypeptide, a human growth hormone 11 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083774A2 Novel mutated form of arginine deiminase
11/08/2001	WO2001083769A2 Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
11/08/2001	WO2001083757A1 Tt virus polypeptide, nucleic acid coding for said polypeptide and uses
11/08/2001	WO2001083754A2 Cellular regulators of infectious agents and methods of use
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083748A1 Novel g protein-coupled receptor protein and dna thereof
11/08/2001	WO2001083747A2 Prion proteins and their uses
11/08/2001	WO2001083746A2 Regulatory nucleic acid sequences of the abc1 gene
11/08/2001	WO2001083743A1 A novel polypeptide, a human red blood cell adducin alpha subunit 11 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083741A1 A novel polypeptide, a myb human protein 10 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083738A1 Sex determinative differentiation regulatory factor
11/08/2001	WO2001083736A2 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof
11/08/2001	WO2001083726A1 A novel polypeptide, a human kinase uridylate 12 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083725A1 Human coagulation factor vii variants
11/08/2001	WO2001083724A1 A new polypeptide - human dihydrooratase 17 and the polynucleotide encoding it
11/08/2001	WO2001083722A2 Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
11/08/2001	WO2001083720A2 23686, a novel human aminotransferase and uses therefor
11/08/2001	WO2001083719A2 25692, a novel human o-methyltransferase family member and uses thereof
11/08/2001	WO2001083718A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
11/08/2001	WO2001083707A2 Chondrocyte cultures and anti-angiogenic fractions therefrom
11/08/2001	WO2001083705A1 Myocardial cell proliferation-associated genes
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083695A2 Dna sequences encoding dystrophin minigenes and methods of use thereof
11/08/2001	WO2001083693A2 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
11/08/2001	WO2001083689A2 PEPTIDES FROM FRAMESHIFT MUTATED DNA POLYMERASE δ GENE
11/08/2001	WO2001083562A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/08/2001	WO2001083557A1 A novel polypeptide, a cellular factor receptor 10 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083556A2 Retina xr receptor
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083552A2 Human sez6 nucleic acids and polypeptides
11/08/2001	WO2001083548A1 Novel derivative of cell chemotactic factor
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083545A1 Novel proetin and use thereof
11/08/2001	WO2001083544A1 A novel polypeptide, a human pax protein 18 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083542A1 A novel polypeptide, human p18 protein 21 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083541A1 A novel polypeptide-human kruppel associated dna binding protein 42 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083540A1 A novel polypeptide-kiaa0883-44 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083539A1 A novel polypeptide, a mitotic kinase ask1-26 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083538A1 A novel polypeptide, a human k-ras gene protein 36 and the polynucleotide
11/08/2001	WO2001083537A1 A novel polypeptide, a human phospholipase 9 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083536A1 A novel polypeptide-cytokine receptor 15 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083533A1 Helicobacter pylori antigens: fusion of hpaa and hpa44
11/08/2001	WO2001083532A1 Helicobacter pylori antigens: fusion of fay 31 and hpa 44
11/08/2001	WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083526A2 Calcitonin-related molecules
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083523A2 Stmst protein and nucleic acid molecules and uses therefor
11/08/2001	WO2001083522A2 Growth factor modified protein matrices for tissue engineering
11/08/2001	WO2001083521A2 Reductive alkylation process on glycopeptides
11/08/2001	WO2001083520A2 Polyacid glycopeptide derivatives
11/08/2001	WO2001083518A2 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
11/08/2001	WO2001083517A1 Stat4 and stat6 binding dipeptide derivatives
11/08/2001	WO2001083516A1 Laminin 15 and uses thereof
11/08/2001	WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	WO2001083513A2 Antisense modulation of inhibitor of dna binding-1 expression
11/08/2001	WO2001083510A1 29 human secreted proteins
11/08/2001	WO2001083508A1 Antisense modulation of zinc finger protein-217 expression
11/08/2001	WO2001083503A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
11/08/2001	WO2001083439A2 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.

1 ... 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 ... 3163